It's a little early to say that, of course, because we are a couple of years away from the real marketing, but the company already has announced that once it is ready, they would basically provide it at production cost. So they wouldn't make any profit from that vaccine. I hope that would mean that we could purchase a dose of vaccine for, let's say, around five dollars maybe, something that would probably be one of the best investments in international public health.
On October 27th, 2011. See this statement in context.